Heart-Healthy diet and walking may cut risks for men on prostate cancer treatment

NCT ID NCT06682390

Recruiting now Disease control Sponsor: University of California, Los Angeles Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a low-calorie, anti-inflammatory diet combined with walking can reduce heart disease risk factors in men with advanced prostate cancer who are on hormone therapy (ADT). Researchers will compare results between African American and non-Hispanic white men to see if they respond differently. The study involves 70 men and lasts about 6 months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER METASTATIC DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

metastatic prostate carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER METASTATIC DISEASE

Contacts and locations

Locations

Greater Los Angeles Division of Veterans Affairs
RECRUITING

Los Angeles, California, 90073, United States
UCLA Health 200 Medical Plaza
RECRUITING

Los Angeles, California, 90095, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.